Hair growth peptides may help support these signaling processes, which may contribute to improved hair density and stronger-looking strands
Add-on to 1-3 oral anti-hyperglycemic agents (metformin, sulfonylurea, or SGLT-2 inhibitor) SURPASS-4 (NCT03730662) was a 104-week open-label trial (52-week primary endpoint) that randomized 2002 adult patients with type 2 diabetes mellitus with increased cardiovascular risk to subcutaneous MOUNJARO 5 mg, MOUNJARO 10 mg, MOUNJARO 15 mg once weekly, or insulin glargine 100 units/mL once daily (1:1:1:3 ratio) on a background of metformin (95%) and/or sulfonylureas (54%) and/or SGLT2 inhibitors (25%)
Phase Low-moderate Daily dose 20-50 mcg/day Site Trained muscle, post-workout Notes Often used in research interest in localized hypertrophy signaling
Our BPC-157 10mg (10 Vials / Kit) is packaged with product stability and research handling requirements in mind to preserve quality throughout storage and transit
Human outcome data is limited
This applies to five-panel, ten-panel, and twelve-panel urinalysis screens